Calcium Levofolinate



Indications and Reactions:

Role Indications Reactions
Primary
Rectal Cancer 87.9%
Colon Cancer 12.1%
Neuropathy Peripheral 50.0%
White Blood Cell Count Decreased 50.0%
Secondary
Colon Cancer 21.7%
Rectal Cancer 14.5%
Colorectal Cancer 11.9%
Colon Cancer Metastatic 10.2%
Large Intestine Carcinoma 9.2%
Drug Use For Unknown Indication 7.5%
Rectal Cancer Metastatic 4.1%
Colorectal Cancer Metastatic 3.5%
Premedication 3.0%
Rectal Cancer Recurrent 3.0%
Prophylaxis 2.6%
Hypertension 1.5%
Colon Cancer Recurrent 1.4%
Prophylaxis Of Nausea And Vomiting 1.0%
Insomnia 1.0%
Duodenal Ulcer Perforation 1.0%
Nausea 0.8%
Gastritis Prophylaxis 0.8%
Cancer Pain 0.7%
Neuropathy Peripheral 0.7%
Interstitial Lung Disease 13.1%
Stomatitis 9.5%
Thrombocytopenia 7.9%
Anaphylactic Shock 7.2%
Vomiting 7.2%
Pyrexia 6.2%
White Blood Cell Count Decreased 5.9%
Gastrointestinal Perforation 4.9%
Shock 4.6%
Rash 3.9%
Duodenal Ulcer Perforation 3.6%
Rectal Perforation 3.3%
Sepsis 3.3%
Duodenal Perforation 3.0%
Hyperammonaemia 3.0%
Porcelain Gallbladder 3.0%
Anaphylactoid Reaction 2.6%
Angina Pectoris 2.6%
Dermatitis Acneiform 2.6%
Leukoencephalopathy 2.6%
Concomitant
Colorectal Cancer 27.1%
Colon Cancer 19.2%
Rectal Cancer 11.4%
Colon Cancer Metastatic 10.3%
Drug Use For Unknown Indication 7.0%
Prophylaxis 5.9%
Premedication 4.8%
Large Intestine Carcinoma 3.3%
Rectal Cancer Metastatic 2.6%
Hypertension 1.2%
Prophylaxis Of Nausea And Vomiting 1.1%
Colon Cancer Recurrent 0.9%
Colorectal Cancer Metastatic 0.9%
Pyrexia 0.9%
Rectal Cancer Recurrent 0.9%
Product Used For Unknown Indication 0.8%
Nausea 0.7%
Benign Prostatic Hyperplasia 0.4%
Rash 0.4%
Gastritis 0.3%
Stomatitis 12.8%
Interstitial Lung Disease 12.3%
White Blood Cell Count Decreased 9.1%
Vomiting 5.9%
Rash 5.5%
Thrombocytopenia 5.5%
Neutropenia 5.2%
Dermatitis Acneiform 4.6%
Neuropathy Peripheral 4.1%
Neutrophil Count Decreased 3.9%
Sepsis 3.9%
Shock 3.6%
Hyperammonaemia 3.4%
Pyrexia 3.4%
Colorectal Cancer 3.0%
Death 3.0%
Hypomagnesaemia 3.0%
Paronychia 3.0%
Hepatic Encephalopathy 2.5%
Pneumonia 2.5%